ロード中...
Anti-TNFα Therapy for Inflammatory Bowel Diseases is Associated With Epstein-Barr Virus Lytic Activation
Anti-TNFα therapy, known to suppress T-cell immunity, is increasingly gaining popularity for treatment of autoimmune diseases including inflammatory bowel diseases (IBD). T-cell suppression increases the risk of B-cell EBV-lymphoproliferative diseases and lymphomas. Since EBV-lytic activation is ess...
保存先:
| 出版年: | J Med Virol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5868340/ https://ncbi.nlm.nih.gov/pubmed/26307954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.24331 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|